VanEck Biotech ETF BBH
255.57 USD +1.07 (+0.42%)
At closeNov 4, 2026, 4:00 AM EST
246.00 -9.57 -3.74%
Pre-market · Nov 4, 4:00 AM ET
255.09 Day range 257.58
178.78 52-week range 262.60
- YTD
- +35.04%
- 1 year
- +43.04%
- Market cap
- 520.48M
- EPS (ttm)
- 8.48
- P/E ratio
- 30.14
- YTD return
- +35.04%
- 1-year return
- +43.04%
- Volume
- 19.77K
- Avg volume
- 11.69K
- Open
- 256.08
- Previous close
- 254.50
- Day's range
- 255.09 – 257.58
- 52-week range
- 178.78 – 262.60
2Y +85.16 (+49.97%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Short % of float
- 0.00%
- 50-day average
- 167.95
- 200-day average
- 169.82
About VanEck Biotech ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
ETFs That You May Consider Amid a Strengthening Biotech Outlook
Judge Hands Natera 30% Ongoing Royalty In MRD Patent Battle
Vertex's New Kidney Drug Delivers Big Trial Win, Stock Jumps Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits
US Judge Weighs Nationwide Ban On Abortion Pills
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug'
Your note
Sign in to keep a note on BBH — it syncs with the Stock Master app.
